Hexarelin has gained significant attention in scientific research for its potential cardioprotective properties, particularly its ability to influence the pathways involved in cardiac hypertrophy and fibrosis. Studies indicate that Hexarelin may help shield heart cells from hypertrophic stress by modulating growth hormone secretagogue receptors and reducing the metabolic strain that contributes to excessive cellular enlargement. Additionally, its anti-fibrotic effects linked to decreased collagen deposition and improved myocardial remodeling suggest a promising role in limiting the progression of cardiac fibrosis. As research continues, Hexarelin stands out as a compelling molecule for investigators exploring innovative strategies to preserve heart function, prevent structural damage, and better understand cardiometabolic health.